Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today…
Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group Sunflower Therapeutics, a public benefit corporation with a mission to transform global access to protein manufacturing capacity, has taken a significant…
Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board In a bold move that underscores its continued investment in science-driven wellness and product development, Tranont, a company known…
Glaukos Reports Financial Results for First Quarter 2025 Glaukos Corporation , a global ophthalmic pharmaceutical and medical technology innovator, delivered a powerful performance in the first quarter of 2025, signaling…
Henry Meds Launches Personalized Hormone Therapies for Menopause Relief Henry Meds, a fast-growing innovator in the telehealth sector, announced a major expansion of its healthcare offerings today with the launch…
Pilatus Biosciences Unveils Preclinical Data on CD36 Antibody PLT012 for Liver Cancer Pilatus Biosciences, a biotechnology company dedicated to developing next-generation immunometabolic therapies for cancer, has announced the publication of…
Revelation Biosciences Advances Development of Gemini Therapy for Infections in Severe Burn Patients Revelation Biosciences, Inc. a clinical-stage life sciences company pioneering approaches to rebalancing inflammation to optimize human health,…
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer In a strategic move to enhance its operational leadership and accelerate the growth of its cutting-edge platforms in induced pluripotent…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research…
Xencor Reports Positive Early Data for Anti-TL1A Antibody in Bowel Disease Xencor, Inc. a leading clinical-stage biopharmaceutical company specializing in the development of engineered antibodies for the treatment of cancer…
Sage Therapeutics Reports Q1 2025 Results and Pipeline Highlights Sage Therapeutics, Inc., a biopharmaceutical company committed to advancing brain health, released its financial results and operational highlights for the first…
QIAGEN Enhances Digital PCR Lineup With New Lentivirus Tools for Cell and Gene Therapy QC In a move that further cements its position as a key player in the evolving…